These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29358298)

  • 1. Unraveling the Metabolic Routes of Retapamulin: Insights into Drug Development of Pleuromutilins.
    Sun F; Zhang H; Gonzales GB; Zhou J; Li Y; Zhang J; Jin Y; Wang Z; Li Y; Cao X; Zhang S; Yang S
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient antibacterial agents: a review of the synthesis, biological evaluation and mechanism of pleuromutilin derivatives.
    Shang R; Wang J; Guo W; Liang J
    Curr Top Med Chem; 2013; 13(24):3013-25. PubMed ID: 24200363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleuromutilin and its derivatives-the lead compounds for novel antibiotics.
    Tang YZ; Liu YH; Chen JX
    Mini Rev Med Chem; 2012 Jan; 12(1):53-61. PubMed ID: 22070694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.
    Yang LP; Keam SJ
    Drugs; 2008; 68(6):855-73. PubMed ID: 18416589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on retapamulin in impetigo and other uncomplicated superficial skin infections.
    Yang LP; Keam SJ
    Am J Clin Dermatol; 2008; 9(6):411-3. PubMed ID: 18973410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.
    Jacobs MR
    Future Microbiol; 2007 Dec; 2(6):591-600. PubMed ID: 18041900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.
    Gentry DR; Rittenhouse SF; McCloskey L; Holmes DJ
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2048-52. PubMed ID: 17404009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of the interactions of the novel pleuromutilin derivative retapamulin with bacterial ribosomes.
    Yan K; Madden L; Choudhry AE; Voigt CS; Copeland RA; Gontarek RR
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3875-81. PubMed ID: 16940066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pleuromutilin antibiotics: a new class for human use.
    Novak R; Shlaes DM
    Curr Opin Investig Drugs; 2010 Feb; 11(2):182-91. PubMed ID: 20112168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo metabolite profiling of valnemulin using ultraperformance liquid chromatography-quadrupole/time-of-flight hybrid mass spectrometry.
    Yang S; Shi W; Hu D; Zhang S; Zhang H; Wang Z; Cheng L; Sun F; Shen J; Cao X
    J Agric Food Chem; 2014 Sep; 62(37):9201-10. PubMed ID: 25156794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleuromutilins: Potent Drugs for Resistant Bugs-Mode of Action and Resistance.
    Paukner S; Riedl R
    Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 27742734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retapamulin: a new topical antibiotic for the treatment of uncomplicated skin infections.
    Parish LC; Parish JL
    Drugs Today (Barc); 2008 Feb; 44(2):91-102. PubMed ID: 18389088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study.
    Oranje AP; Chosidow O; Sacchidanand S; Todd G; Singh K; Scangarella N; Shawar R; Twynholm M;
    Dermatology; 2007; 215(4):331-40. PubMed ID: 17911992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retapamulin: a newer topical antibiotic.
    Dhingra D; Parakh A; Ramachandran S
    J Postgrad Med; 2013; 59(2):127-30. PubMed ID: 23793314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of retapamulin, a novel pleuromutilin for topical use.
    Rittenhouse S; Biswas S; Broskey J; McCloskey L; Moore T; Vasey S; West J; Zalacain M; Zonis R; Payne D
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3882-5. PubMed ID: 17065625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.
    Scangarella-Oman NE; Shawar RM; Bouchillon S; Hoban D
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):269-79. PubMed ID: 19344241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antibiotic tiamulin is a potent inducer and inhibitor of cytochrome P4503A via the formation of a stable metabolic intermediate complex. Studies in primary hepatocyte cultures and liver microsomes of the pig.
    Witkamp RF; Nijmeijer SM; Monshouwer M; Van Miert AS
    Drug Metab Dispos; 1995 May; 23(5):542-7. PubMed ID: 7587928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci.
    Jones RN; Fritsche TR; Sader HS; Ross JE
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2583-6. PubMed ID: 16801451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Tiamulin Metabolites in Various Species of Farm Animals Using Ultra-High-Performance Liquid Chromatography Coupled to Quadrupole/Time-of-Flight.
    Sun F; Yang S; Zhang H; Zhou J; Li Y; Zhang J; Jin Y; Wang Z; Li Y; Shen J; Zhang S; Cao X
    J Agric Food Chem; 2017 Jan; 65(1):199-207. PubMed ID: 28026174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial.
    Koning S; van der Wouden JC; Chosidow O; Twynholm M; Singh KP; Scangarella N; Oranje AP
    Br J Dermatol; 2008 May; 158(5):1077-82. PubMed ID: 18341664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.